๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
587 medicines starting with โ€œLโ€
MedicineActive substanceLicence holderStatus
Lipocomb 10 mg/10 mg hard capsules
PA1470/004/001
Ezetimibe, Rosuvastatin zinc tetrahydrate EGIS Pharmaceuticals PLC Not marketed
Lipocomb 10 mg/10 mg hard capsules
PPA0465/460/001
Ezetimibe, Rosuvastatin PCO Manufacturing Ltd. โ€”
Lipocomb 20 mg/10 mg hard capsules
PA1470/004/002
Ezetimibe, Rosuvastatin zinc tetrahydrate EGIS Pharmaceuticals PLC Not marketed
Lipocomb 20 mg/10 mg hard capsules
PPA0465/460/002
Rosuvastatin, Ezetimibe PCO Manufacturing Ltd. โ€”
Lipocomb 40 mg/10 mg hard capsules
PA1470/004/003
Ezetimibe, Rosuvastatin zinc tetrahydrate EGIS Pharmaceuticals PLC Marketed
Liposic 2 mg/g eye gel
PA23259/009/001
Carbomer Bausch + Lomb Ireland Limited Marketed
Liprolog
EU/1/01/195/028-029
Eli Lilly and Company Limited โ€”
Liprolog
EU/1/01/195/22-27
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog 100 units/ml, solution for injection in vial
EU/1/01/195/001
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog 100 units/ml, solution for injection in vial
EU/1/01/195/002
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix25
EU/1/01/195/003
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix25 Pen
EU/1/01/195/006
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix50
EU/1/01/195/004
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix50 Pen
EU/1/01/195/007
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog-Pen
EU/1/01/195/005
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liquid Medical Oxygen 100% Medicinal gas, cryogenic
PA1848/005/001
Oxygen SOL S.p.A. โ€”
Liquid Medical Oxygen 100% Medicinal gas, cryogenic
PA1848/005/002
Oxygen SOL S.p.A. โ€”
LIQUIVISC 2.5 mg/g eye gel
PA1107/002/001
Carbomer Laboratoires Thea Marketed
Lirepin 400 mg film-coated tablets
PA1701/013/001
Ibuprofen lysine Zentiva k.s. Not marketed
Lisdexamfetamine dimesylate Rowex 20 mg hard capsules
PA0711/352/001
Lisdexamfetamine dimesylate Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 30 mg hard capsules
PA0711/352/002
Lisdexamfetamine dimesylate Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 40 mg hard capsules
PA0711/352/003
Lisdexamfetamine dimesylate Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 50 mg hard capsules
PA0711/352/004
Lisdexamfetamine dimesylate Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 60 mg hard capsules
PA0711/352/005
Lisdexamfetamine dimesylate Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 70 mg hard capsules
PA0711/352/006
Lisdexamfetamine dimesylate Rowex Limited, Not marketed
Lisinopril 1 mg/ml Oral Solution
PA23081/013/001
Lisinopril Dihydrate Taw Pharma (Ireland) Limited Not marketed
Lisinopril Grindeks 10 mg tablets
PA22992/018/002
Lisinopril Dihydrate AS Grindeks Not marketed
Lisinopril Grindeks 20 mg tablets
PA22992/018/003
Lisinopril Dihydrate AS Grindeks Not marketed
Lisinopril Grindeks 5 mg tablets
PA22992/018/001
Lisinopril Dihydrate AS Grindeks Not marketed
Lisopress 10 mg tablets
PA1330/013/003
Lisinopril Dihydrate Gedeon Richter Plc Marketed
Lisopress 20 mg tablets
PA1330/013/004
Lisinopril Dihydrate Gedeon Richter Plc Marketed
Lisopress 5 mg tablets
PA1330/013/002
Lisinopril Dihydrate Gedeon Richter Plc Marketed
Lispril 10 mg Tablets
PA0711/047/003
Lisinopril (as dihydrate) Rowex Limited, Marketed
Lispril 20 mg Tablets
PA0711/047/004
Lisinopril (as dihydrate) Rowex Limited, Marketed
Lispril 5 mg Tablets
PA0711/047/002
Lisinopril Dihydrate Rowex Limited, Marketed
Lispril-Hydrochlorothiazide 10 mg/12.5 mg tablets
PA0711/051/001
Lisinopril Dihydrate, Hydrochlorothiazide Rowex Limited, Marketed
Lispril-Hydrochlorothiazide 20 mg/12.5 mg tablets
PA0711/051/002
Lisinopril Dihydrate, Hydrochlorothiazide Rowex Limited, Marketed
Litak 2 mg/ml solution for injection
EU/1/04/275/001-002
Cladribine Lipomed GmbH โ€”
Litfulo 50 mg hard capsules
EU/1/23/1755/001-003
Ritlecitinib Pfizer Europe MA EEIG โ€”
Lithium Chloride 0.15 mmol/ml. Solution for Injection
PA23039/001/001
Lithium chloride LiDCO Netherlands B.V. Marketed
Livazo 1mg film-coated tablets
PA2324/001/001
Pitavastatin Kowa Pharmaceutical Europe GmbH Not marketed
Livazo 2mg film-coated tablets
PA2324/001/002
Pitavastatin Kowa Pharmaceutical Europe GmbH Not marketed
Livazo 4mg film-coated tablets
PA2324/001/003
Pitavastatin Kowa Pharmaceutical Europe GmbH Not marketed
Livial 2.5 mg tablets
PA23198/021/001
Tibolone Organon Pharma (Ireland) Limited Marketed
Livmarli 9.5 mg/mL oral solution
EU/1/22/1704/001
Maralixibat Chloride Mirum Pharmaceuticals International B.V. โ€”
Livogiva 20 micrograms/80 microliters solution for injection in pre-filled pen
EU/1/20/1462/001-002
Teriparatide Theramex Ireland Limited โ€”
LIVTENCITY 200 mg film-coated tablets
EU/1/22/1672/001-002
Maribavir Takeda Pharmaceuticals International AG Ireland Branch โ€”
Lixiana 15 mg film-coated tablets
EU/1/15/993/001
Edoxaban tosilate Daiichi Sankyo Europe GmbH โ€”
Lixiana 30 mg film-coated tablets
EU/1/15/993/002
Edoxaban tosilate Daiichi Sankyo Europe GmbH โ€”
Lixiana 60 mg film-coated tablets
EU/1/15/993/003
Edoxaban tosilate Daiichi Sankyo Europe GmbH โ€”
โ† 6 7 8 9 10 11 12 โ†’
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.